Search results for: J.-Matthias Graf von der Schulenburg

Items from 1 to 20 out of 46 results

article

Brief des Schriftleiters an die Leser

J.-Matthias Graf von der Schulenburg

Zeitschrift für die gesamte Versicherungswissenschaft > 2018 > 107 > 4 > 329-331

article

“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations

Thomas R. Staab, Miriam Walter, Sonja Mariotti Nesurini, Charalabos-Markos Dintsios, more

Health Economics Review > 2018 > 8 > 1 > 1-11

Background According to the AMNOG act, the German Federal Joint Committee (G-BA) determines the additional benefit of new medicines as a basis for subsequent price negotiations. Pharmaceutical companies may withdraw their medications from the market at any time during the process. This analysis aims to compare recommendations in clinical guidelines and HTA appraisals of medicines that were withdrawn...

article

Rückblick und Danksagung

J.-Matthias Graf von der Schulenburg

Zeitschrift für die gesamte Versicherungswissenschaft > 2018 > 107 > 1 > 1-2

article

German Value Set for the EQ-5D-5L

Kristina Ludwig, J.-Matthias Graf von der Schulenburg, Wolfgang Greiner

PharmacoEconomics > 2018 > 36 > 6 > 663-674

Objectives The objective of this study was to develop a value set for EQ-5D-5L based on the societal preferences of the German population. As the first country to do so, the study design used the improved EQ-5D-5L valuation protocol 2.0 developed by the EuroQol Group, including a feedback module as internal validation and a quality control process that was missing in the first wave of EQ-5D-5L valuation...

article

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany

Ana Babac, Martin Frank, Frédéric Pauer, Svenja Litzkendorf, more

BMC Health Services Research > 2018 > 18 > 1 > 1-14

Background Rare diseases are, by definition, very serious and chronic diseases with a high negative impact on quality of life. Approximately 350 million people worldwide live with rare diseases. The resulting high disease burden triggers health information search, but helpful, high-quality, and up-to-date information is often hard to find. Therefore, the improvement of health information provision...

article

Priorisierung und Rationierung von Arzneimittel – eine experimentelle Analyse von Diskussionsprozessen

Ines Aumann, Svenja Litzkendorf, Kathrin Damm, J. Matthias Graf von der Schulenburg

Zeitschrift f�r Evidenz, Fortbildung und Qualit�t im Gesundheitswesen > 2017 > 125 > C > 3-13

In the face of rising expenditure among statutory sickness funds in Germany it is necessary to start a discussion about priority setting in the healthcare system. For a long time this issue has been avoided in healthcare debates. As a result, normative directives are still missing, which can lead to priority setting among healthcare providers in daily healthcare practice. Prioritization can be conducted...

article

Editorial

J.-Matthias Graf von der Schulenburg

Zeitschrift für die gesamte Versicherungswissenschaft > 2017 > 106 > 1 > 1-2

article

Zentrales Informationsportal über seltene Erkrankungen

Svenja Litzkendorf, Frédéric Pauer, Jan Zeidler, Jens Göbel, more

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz > 2017 > 60 > 5 > 494-502

Hintergrund Ein zentrales Informationsportal über seltene Erkrankungen wurde etabliert, über das u. a. Betroffene und Angehörige auf hochwertige Informationen zugreifen können. Hierfür wurden Qualitätskriterien entwickelt, die speziell auf Seiten über seltene Erkrankungen ausgerichtet sind. Gleichzeitig soll das Informationsangebot die Bedarfe von Betroffenen berücksichtigen. Ziel der Arbeit Zunächst...

article

Rare cancers—Rarity as a cost and value argument

J.-Matthias Graf von der Schulenburg, Frédéric Pauer

Journal of Cancer Policy > 2017 > 11 > C > 54-59

Here is a paradox in medicine: rare diseases are unusual, but developing a rare disease is quite frequent. This is also true for rare forms of cancer. Almost every 20th person in the world suffers from a rare disease, and about one quarter of all new diagnosed cancers belong to rare cancers. The downside of rare diseases for patients is the difficulty to find the right institution for their treatment,...

article

Evaluation der hausarztzentrierten Versorgung in Deutschland anhand von GKV-Routinedaten der AOK Rheinland/Hamburg

Mike Klora, Jan Zeidler, Melanie May, Nils Raabe, more

Zeitschrift f�r Evidenz, Fortbildung und Qualit�t im Gesundheitswesen > 2017 > 120 > C > 21-30

Health insurance funds in Germany are obliged to offer family doctor-centred health care models (Hausarztzentrierte Versorgung, “HzV”). The participation is voluntary for the insured persons. Participants agree to utilise outpatient specialist care only if their family doctor or general practitioner (“gatekeeper”) refers them to a specialist. The aim of this programme is to both strengthen the role...

article

Ganzgenomsequenzierung in der deutschen Versorgung

Marika Plöthner, Martin Frank, J.-Matthias Graf von der Schulenburg

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz > 2017 > 60 > 2 > 143-150

Hintergrund Der Einsatz von Whole-Genome Sequencing (WGS) wird in der klinischen Versorgung vermehrt diskutiert. Aufgrund der begrenzten Ressourcen im Gesundheitswesen sind Budget-Impact-Analysen notwendig, um die potenziellen Auswirkungen eines Einsatzes von WGS abschätzen zu können. Ziel der Arbeit Die ökonomischen Auswirkungen eines Einsatzes von WGS wurden sowohl im Rahmen des Neugeborenenscreenings...

book

Übungen zur Versicherungsökonomik

J.-Matthias Graf von der Schulenburg, Andy Zuchandke

Springer-Lehrbuch

Das Buch bietet ein breites Spektrum an versicherungsökonomischen Übungsaufgaben. Die Themenbereiche umfassen u.a. versicherungstechnische Grundlagen, Entscheidungen unter Unsicherheit, Theorie von Versicherungsnachfrage und -angebot sowie staatliche Regulierung und Sozialversicherung. Zu allen Aufgaben werden umfangreiche Musterlösungen präsentiert. Das Übungsbuch ist besonders geeignet für versicherungsökonomische...

article

Editorial

J.-Matthias Graf von der Schulenburg

Zeitschrift für die gesamte Versicherungswissenschaft > 2016 > 105 > 1 > 1-1

article

Benefit assessment in Germany: implications for price discounts

Ulrike Theidel, J-Matthias Graf von der Schulenburg

Health Economics Review > 2016 > 6 > 1 > 1-12

Background The AMNOG regulation, introduced in 2011 in Germany, changed the game for new drugs. Now, the industry is required to submit a dossier to the GBA (the central decision body in the German sickness fund system) to show additional benefit. After granting the magnitude of the additional benefit by the GBA, the manufacturer is entitled to negotiate the reimbursement price with the GKV-SV (National...

article

Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases

Frédéric Pauer, Katharina Schmidt, Ana Babac, Kathrin Damm, more

BMC Medical Informatics and Decision Making > 2016 > 16 > 1 > 1-11

Background The Analytic Hierarchy Process (AHP) is increasingly used to measure patient priorities. Studies have shown that there are several different approaches to data acquisition and data aggregation. The aim of this study was to measure the information needs of patients having a rare disease and to analyze the effects of these different AHP approaches. The ranking of information needs is then...

article

Die Versorgung von Menschen mit seltenen Erkrankungen in Niedersachsen: Ergebnisse einer Ärztebefragung

Frédéric Pauer, Uljana Pflaum, Verena Lührs, Martin Frank, more

Zeitschrift f�r Evidenz, Fortbildung und Qualit�t im Gesundheitswesen > 2016 > 113 > C > 36-44

In the European Union, about 30 million people are affected by one of the 7,000 to 8,000 diseases being defined as rare. In Germany alone, an estimated 4 million people suffer from a rare disease. In many cases, therapeutic options and knowledge of specific rare diseases are strongly limited.The aim of this study was to identify the deficits and challenges confronting healthcare services for people...

article

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -

Mike Klora, Jan Zeidler, Roland Linder, Frank Verheyen, more

Health Economics Review > 2015 > 5 > 1 > 1-9

Background and objectives The costs and treatment patterns of attention deficit hyperactivity disorder (ADHD) are subjects of health services research in Germany and worldwide. Previous publications focused mainly on prevalent patients and thus research gaps were identified regarding costs and treatment patterns of incident patients before and after the first diagnosis. Methods Analyses were conducted...

article

The Role of decision-analytic modelling in German health technology assessments

Alexander Kuhlmann, Marina Treskova, Sebastian Braun, J-Matthias Graf von der Schulenburg

Health Economics Review > 2015 > 5 > 1 > 1-7

Background Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical Documentation and Information (DIMDI). Our study examines the use of DAM in DIMDI HTA reports and its effect...

article

Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting

Katharina Schmidt, Ines Aumann, Ines Hollander, Kathrin Damm, more

BMC Medical Informatics and Decision Making > 2015 > 15 > 1 > 1-27

Background The Analytic Hierarchy Process (AHP), developed by Saaty in the late 1970s, is one of the methods for multi-criteria decision making. The AHP disaggregates a complex decision problem into different hierarchical levels. The weight for each criterion and alternative are judged in pairwise comparisons and priorities are calculated by the Eigenvector method. The slowly increasing application...

article

Bank dividend policy and the global financial crisis: Empirical evidence from Europe

Tobias Basse, Sebastian Reddemann, Johannes-Jörg Riegler, J.-Matthias Graf von der Schulenburg

European Journal of Political Economy > 2014 > 34 > Supplement > S25-S31

The global financial crisis has caused controversial discussions about the capital base of the banking industry in Europe. Dividend cuts and omissions have been suggested as one possibility to improve the financial strength of banks by retaining earnings. However, there are fears that investors could interpret a reduction of dividends as a sign for future problems. The dividend signalling and dividend...

Publication date

Set your own date range

Keywords

Data set

Springer (31)
Elsevier (15)

Journal

Health Economics Review (8)
Zeitschrift für die gesamte Versicherungswissenschaft (7)
PharmacoEconomics German Research Articles (4)
Health policy (3)
The European Journal of Health Economics (3)
Zeitschrift f�r Evidenz, Fortbildung und Qualit�t im Gesundheitswesen (3)
BMC Medical Informatics and Decision Making (2)
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2)
Social Science & Medicine (2)
Value in Health (2)
BMC Health Services Research (1)
European Journal of Political Economy (1)
Herz (1)
Journal of Cancer Policy (1)
Journal of Hepatology (1)
Medizinrecht (1)
PharmacoEconomics (1)
Public Health Forum (1)
Radiotherapy and Oncology (1)
more

INFONA - science communication portal

Search results for: J.-Matthias Graf von der Schulenburg

Brief des Schriftleiters an die Leser

“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations

Rückblick und Danksagung

German Value Set for the EQ-5D-5L

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany

Priorisierung und Rationierung von Arzneimittel – eine experimentelle Analyse von Diskussionsprozessen

Editorial

Zentrales Informationsportal über seltene Erkrankungen

Rare cancers—Rarity as a cost and value argument

Evaluation der hausarztzentrierten Versorgung in Deutschland anhand von GKV-Routinedaten der AOK Rheinland/Hamburg

Ganzgenomsequenzierung in der deutschen Versorgung

Übungen zur Versicherungsökonomik

Editorial

Benefit assessment in Germany: implications for price discounts

Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases

Die Versorgung von Menschen mit seltenen Erkrankungen in Niedersachsen: Ergebnisse einer Ärztebefragung

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -

The Role of decision-analytic modelling in German health technology assessments

Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting

Bank dividend policy and the global financial crisis: Empirical evidence from Europe

Filter options

Publication date

Content availability

Publication type

Publication language

Keywords

Data set

Journal

INFONA - science communication portal

Search results for: J.-Matthias Graf von der Schulenburg

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Content availability

Publication type

Publication language

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options